Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Biotime Inc (BTX)

3.18 +0.03 (+0.95%)

6/23/2017  4:01pm

Open:

3.15

Pre. Close:

3.15

High:

3.19

Low:

3.06

Volume:

2,148,525

Market Cap:

352.58M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.23 - 3.27

3.27 - 3.35

Low:

2.9 - 2.94

2.94 - 3.03

Close:

3.06 - 3.14

3.14 - 3.3

Technical analysis  (as of: 2017-06-23 4:32:52 PM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 3.99     One year: 4.67

Support:

Support1: 3.10    Support2: 2.90

Resistance:

Resistance1: 3.42    Resistance2: 3.99

Pivot:

3.10

Moving Averages:

MA(5): 3.06     MA(20): 3.12

MA(100): 3.19     MA(250): 3.26

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 36.67     %D(3): 23.33

RSI:

RSI(14): 53.27

52-Week:

High: 4.01  Low: 2.26  Change(%): 29.8

Average Vol(K):

3-Month: 17732  10-Days 602

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BTX has closed below upper band by 27.1%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 11 Dec 2012 15:00:02 GMT
0.19

Wed, 07 Jun 2017 21:03:02 GMT
AtmanCo Announces the Conversion of 5000000 Warrants Into Shares

Thu, 09 Jun 2016 13:30:00 GMT
AtmanCo Announces Signature of a Letter of Intent for the Acquisition of ...

Thu, 05 May 2016 12:56:15 GMT
AtmanCo Releases First-Quarter 2016 Financial Results

Thu, 25 May 2017 19:52:30 GMT
AtmanCo Announces Revenue Growth of $2.5 Million for Its First Quarter of 2017

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

110.88

Shares Float (M)

75.25

% Held by Insiders

46.22

% Held by Institutions

14.90

Shares Short (K)

5290

Shares Short Prior Month (K)

5300

Stock Financials

EPS

0.970

EPS Est. Current Year

0.190

EPS Est. Next Year

-0.370

EPS Est. Next Quarter

-0.080

Forward EPS

-0.370

Book Value (p.s.)

1.690

PEG Ratio

Profit Margin

2357.83

Operating Margin

-1096.01

Return on Assets (ttm)

-20.4

Return on Equity (ttm)

71.9

Qtrly Rev. Growth

-81.2

Gross Profit (p.s.)

0.050

Sales Per Share

EBITDA (p.s.)

-0.385

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.11

Levered Free Cash Flow (M)

-27.04

FoxReading.com

Valuation

P/E

3.28

P/E Growth Ratio

0.01

P/BV

1.88

P/S

8814959616.00

P/CF

-9.76

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

3

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.